ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weiss, S.T.
Right arrow Articles by Postma, D.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weiss, S.T.
Right arrow Articles by Postma, D.S.
Eur Respir J 2003; 21:4S-12S
Copyright ©ERS Journals Ltd 2003


COPD: problems in diagnosis and measurement

S.T. Weiss1, D.L. DeMeo1 and D.S. Postma2

1 Channing Laboratory, Brigham & Women's Hospital, Boston, MA, USA. 2 University Hospital, Groningen, The Netherlands

CORRESPONDENCE: S.T. Weiss, 181 Longwood Avenue, Channing Laboratory, Boston, MA 02115, USA. Fax: 1 6175252745. E-mail: Scott.weiss@channing.harvard.edu

Keywords: airway hyperresponsiveness, comorbidities, exacerbation, pulmonary function testing, outcome measurement

Received: August 21, 2002
Accepted February 20, 2003

Chronic obstructive pulmonary disease (COPD) is the most rapidly rising cause of death in individuals >65 yrs of age, the most rapidly growing segment of the USA population.

Advancing the clinical research agenda for COPD entails careful consideration of several issues and problems: defining COPD, reliance on physiological testing, outcome measurements and comorbidities.

In addition, issues pertaining to the recent dramatic increase in chronic obstructive pulmonary disease mortality in females, smoking susceptibility and the relationship of respiratory symptoms with hyperresponsiveness, as well as chronic obstructive pulmonary disease heterogeneity, are discussed.




This article has been cited by other articles:


Home page
ChestHome page
A. Caballero, C. A. Torres-Duque, C. Jaramillo, F. Bolivar, F. Sanabria, P. Osorio, C. Orduz, D. P. Guevara, and D. Maldonado
Prevalence of COPD in Five Colombian Cities Situated at Low, Medium, and High Altitude (PREPOCOL Study)
Chest, February 1, 2008; 133(2): 343 - 349.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the European Respiratory Society.